The rapid development and growing accessibility of artificial intelligence (AI), and the expanding use of AI in the life sciences sector, are becoming increasingly important factors in the continuing evolution of pharmaceutical industry compliance, and government enforcement efforts.
But the use of AI comes with unanswered questions over its incorporation